National clinical research programme into early diagnosis of Alzheimer’s disease

March 2016

Share to Twitter Share to Facebook Share to LinkedIn Send by email

Alliance Medical is contributing 2,000 scans, together with radio tracers, to a national clinical research programme to support early diagnosis of Alzheimer’s disease. It is part of a wider initiative to improve research access to PET-CT scanners across the country which will see leading academic institutions and local clinicians collaborating on trials across a range of diseases and disorders including Alzheimer’s disease, cancer and heart disease.

The programme is made possible thanks to the Molecular Imaging Collaborative Network (MICN), led by Alliance Medical, which has been commissioned to provide PET-CT scanning services across 31 locations in England. As well as upgrading many scanners to state-of-the-art static units, the MICN has undertaken to provide additional capacity for research - standardising and accrediting all scanners to create a national vertically integrated PET-CT network for clinical, research and trial use that is arguably the largest in the world.   

The national PET-CT network allows research collaboration between local clinicians and leading academic centres.

Each of the 31 centres will have NCRI accreditation to allow local participation in multi-centre trials, coordinated by the new Christie Academy of Advanced Imaging.  This will be enhanced through standardised procedures across the MICN network.

This research will have a real impact on patient outcomes by enabling data to be published faster than before and allowing best practice to be determined and implemented across the country.

As Chair of the Alliance Medical Molecular Imaging Governance Committee (AMMICG), I am looking forward to providing a network of high quality scanning which will provide robust evidence of the benefit of PET-CT in clinical care, and to providing an improved pathway for trialling new imaging agents and technologies.
Professor Fergus Gleeson
Chair of AMMICG

To discuss your own specific imaging needs, please contact us.


Read more of our partnership case studies

AML Quality Account 2020/21

The report has now been finalised and is ready for download


View profiles of our UK Board and Management Team

Our story

Learn more about our history and growth


Corporate governance and quality assured service excellence

Alliance Medical are Europe’s leading independent provider of medical imaging services. 

We combine service excellence and innovative imaging technologies to improve patient care and support NHS and independent sector organisations with their ongoing imaging requirements. Our approach has delivered consistent company growth for more than 25 years.


Close menu

Current vacancies

Visit our jobs site to view latest vacancies, register as a candidate and apply for jobs.

Search vacancies now

Carrying out over 2 million scans per year, we set our standards high when it comes to our people and their careers. Investment in integrated systems and individual expertise allows the development of services and long term partnerships to be forged which has seen us grow to be the imaging healthcare provider of choice for patients, referrers and employees.
Quality, safety and transparency underpin all the we do.
Close menu

Alliance Medical is Europe’s leading diagnostic and molecular imaging services provider delivering high quality diagnostic solutions in partnership with public organisations.  

We form an effective part of the health economy in each of the countries in which we operate and see our role as supporting the existing healthcare infrastructure, providing innovative partnership solutions to address local challenges in a way that builds on the strengths of existing core services.

Close menu